NRXS — Neuraxis Cashflow Statement
0.000.00%
Last trade - 00:00- $19.42m
- $17.51m
- $2.69m
Annual cashflow statement for Neuraxis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.73 | -3.03 | -4.78 | -14.6 | -8.24 |
| Depreciation | |||||
| Non-Cash Items | -0.154 | 0.113 | 1.17 | 8.56 | 1.96 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.295 | 0.644 | 1.27 | -0.666 | 0.141 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -4.14 | -2.23 | -2.3 | -6.69 | -6.1 |
| Capital Expenditures | -0.028 | -0.001 | -0.061 | -0.072 | -0.028 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.028 | -0.001 | -0.061 | -0.072 | -0.028 |
| Financing Cash Flow Items | — | — | -0.737 | -0.552 | -0.195 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.05 | 0.661 | 2.29 | 6.59 | 9.74 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.89 | -1.57 | -0.067 | -0.175 | 3.62 |